Long-term outcomes after intracoronary β-irradiation for in-stent restenosis in bare-metal stents

Journal of Invasive Cardiology

Volumn 20, Issue 4, 2008, Pages 179-184

  Maeder, Micha T ^a   Pfisterer, Matthias E ^a   Buser, Peter T ^a   Roser, Hans W ^a   Roth, Jakob ^a   Weilenmann, Daniel ^a   Nietlispach, Fabian P ^a   Zellweger, Michael J ^a   Amsler, Beat ^a   Kaiser, Christoph A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Angioplasty; Beta radiation; Brachytherapy; Gamma radiation; In stent restenosis; Outcomes

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; CORONARY STENT; ELECTRON THERAPY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RESTENOSIS; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; BRACHYTHERAPY; CORONARY RESTENOSIS; FEMALE; GAMMA RAYS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; SAPHENOUS VEIN; STENTS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 41849098150     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101:1895-1898.
2. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256.
3. Waksman R, Cheneau E, Ajani AE, et al. Washington Radiation for In-Stent restenosis Trial for Long Lesions Studies. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: Results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003;107:1744-1749.
4. Popma JJ, Suntharalingam M, Lansky AJ, et al. Stents And Radiation Therapy (START) Investigators. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-1096.
5. Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: The INHIBIT randomised controlled trial. Lancet 2002;359:551-557.
6. Mukherjee D, Moliterno DJ. Brachytherapy for in-stent restenosis: a distant second choice to drug-eluting stent placement. JAMA 2006;295:1307-1309.
7. Waksman R, Bhargava B, Mintz GS, et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol 2000;36:65-68.
8. Holmes DR Jr, Teirstein P, Satler L, et al.; SISR Investigators. Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: The SISR randomized trial. JAMA 2006;295:1264-1273.
9. Stone GW, Ellis SG, O'Shaughnessy CD, et al. TAXUS V ISR Investigators. Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial. JAMA 2006;295:1253-1263.
10. Nikas DN, Kalef-Ezra J, Katsouras CS, et al. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice. Int J Cardiol 2007;115:183-189.
11. Gruberg L, Caiati R, Aronson D, et al. Five-year clinical follow up after intracoronary radiation for the prevention of in-stent restenosis. J Invasive Cardiol 2006;18:494-498.
12. Grise MA, Massullo V, Jani S, et al. Five-year clinical follow-up after intracoronary radiation: Results of a randomized clinical trial. Circulation 2002;105:2737-2740.
13. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial. Circulation 2000;101:360-365.
14. Iofina E, Radke P, Schubert D, et al. Three-year follow-up after intracoronary beta-radiation therapy for in-stent restenosis. Catheter Cardiovasc Interv 2006;67:600-606.
15. Sianos G, Hoye A, Saia F, et al. Long term outcome after intracoronary beta radiation therapy. Heart 2005;91:942-947.
16. Waksman R, Ajani AE, White RL, et al. Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis. Circulation 2004;109:340-344.
17. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591.
18. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-1039.
19. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet 2007;369:667-678.
20. Lagerqvist B, James SK, Stenestrand U, et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019.
21. Raizner AE, Kaluza GL, Ali NM. Clinical experience with a spiral balloon centering catheter for the delivery of intracoronary radiation therapy. Cardiovasc Radiat Med 1999;1:214-219.
22. Cutlip DE, Windecker S, Mehran R, et al. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
23. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-1878.
24. Kaiser C, Brunner-La Rocca HP, Buser PT, et al. BASKET Investigators. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005;366:921-929.
25. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
26. Togni M, Windecker S, Wenaweser P, et al. Deleterious effect of coronary brachytherapy on vasomotor response to exercise. Circulation 2004;110:135-140.
27. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:e166-e286.